Supplementary Tables from Low Recombination Proficiency Score (RPS) Predicts Heightened Sensitivity to DNA-Damaging Chemotherapy in Breast Cancer

This file includes Supplementary Tables S1-S5. Table S1: Eligible neoadjuvant chemotherapy breast cancer datasets. Table S2: Reference breast cancer datasets for gene expression normalization. Table S3: List of duplicate samples excluded from study. Table S4: Test characteristics of a reduced gene model. Table S5: RPS values for study patients.